1. USD

    84.14

    Today's change

    -0.37 / -0.44%

    1 year change

    +38.66%

    As of Aug 03 2015 21:02 BST. Data delayed by at least 15 minutes.

Search for Eli Lilly & Co and
  1. July 24, 2015

    Week in Review, July 25

    A round up of some of the week’s most significant corporate events and news stories. Credit Suisse soars on back of...

  2. July 22, 2015

    Eli Lilly: think it through

    The search for a cure for the degenerative disease Alzheimer’s has been long and hard. Billions have been spent....

Special Reports

  1. Combating Diabetes

    Urbanisation, poor diet and failure to exercise have led to record levels of obesity, ...
  2. Special Report: Boldness in Business 2012

    Seven success stories are honoured in this year’s awards...
Search more Special Reports on this topic.

  1. July 22, 2015

    Alzheimer’s breakthrough hopes add to promise of pharma revival

    Hopes of a breakthrough against Alzheimer’s disease have been boosted by encouraging clinical trial data from Eli Lilly...

  2. July 22, 2015

    Eli Lilly raises hopes for breakthrough Alzheimer’s drug

    Eli Lilly has raised hopes for a breakthrough in the treatment of Alzheimer’s disease after unveiling evidence that its...

  3. July 19, 2015

    Pharmaceuticals: Brain power

    Garbed in white lab coat and goggles, a young scientist carefully cuts a mouse’s brain into wafer thin slices. She adds...

  4. July 17, 2015

    Cautionary tale as Receptos benefits from buying frenzy

    If you can’t beat ’em, buy ’em. That seems to be the mantra this week after Celgene agreed to pay $7.2bn for the maker...

  5. July 16, 2015

    Immunocore in record European biotech raising

    Immunocore, the Oxford-based cancer drug developer, has secured $320m in the biggest private fundraising by a European...

  6. July 1, 2015

    Pharma groups eye healthy returns from animal drugs market

    A treatment for dogs with itchy skin has turned out to be something of a tonic for investors. Apoquel launched last...

  7. June 29, 2015

    Eli Lilly and Immunocore in cocktail collaboration against cancer

    Eli Lilly of the US is to expand its alliance with Immunocore of the UK in the latest example of pharmaceuticals...

  8. June 25, 2015

    Johnson floats £10bn biotech fund for London

    Plans for a £10bn fund to boost investment in life sciences have been floated by Boris Johnson, London mayor, as part...

  9. April 29, 2015

    Takeda to pay $2.7bn to settle Actos cancer claims

    In one of the largest product liability settlements to date, Takeda Pharmaceutical has agreed to pay $2.7bn over claims...

  10. April 5, 2015

    UK reprieve for three cancer drugs

    Three cancer drugs that were supposed to be removed from the National Health Service on cost grounds have been granted...

  11. March 27, 2015

    Insulin: moving the needle

    It has been a sweet run. The biggest companies in the insulin business — Sanofi, Novo Nordisk, and Eli Lilly — have...

  12. March 26, 2015

    Indiana signs ‘religious freedom’ bill

    Indiana Governor Mike Pence has signed a bill that would allow businesses to refuse service to gay and lesbian patrons...

  13. March 20, 2015

    Biogen’s Alzheimer’s drug shows early promise

    An experimental Alzheimer’s drug being developed by a US biotech group has offered hope that scientists may be closer...

  14. March 17, 2015

    Dementia research boosted by $100m venture capital fund

    Research into dementia is to be boosted by a $100m venture capital fund backed by the UK government and several of the...

  15. February 24, 2015

    Eli Lilly stays out of deals fray as it eyes ‘moon shot’ drugs

    The pharmaceutical industry is gripped by deals fever, but one company is conspicuously absent from the lists of...

  16. February 2, 2015

    Big pharmaceuticals groups faces biosimilars challenge

    Global pharmaceuticals companies have seen an improvement in their drugs pipelines but the industry is facing a fresh...

  17. December 11, 2014

    Broker’s upgrade boosts Eli Lilly shares

    Eli Lilly shares were buoyed by a brokerage upgrade on Thursday as Morgan Stanley analysts gained confidence over the...

  18. November 13, 2014

    Spread of city life destroys myth of diabetes as a western illness

    Which country has the most diabetics? The US seems the obvious candidate given its high rate of obesity – the main...

  19. November 13, 2014

    Diabetes researchers find hope in link with dementia

    From his office at the Hammersmith Hospital in west London, Dr Paul Edison has begun the search for patients to...

  20. September 16, 2014

    AstraZeneca and Eli Lilly to unite for Alzheimer’s drug challenge

    AstraZeneca has struck a deal to jointly develop a treatment for Alzheimer’s disease with Eli Lilly of the US in a...

  21. September 16, 2014

    AstraZeneca swallows bittersweet pill with Eli Lilly Alzheimer’s deal

    Consciousness, the lens through which humans perceive the world, is ill-adapted for perceiving itself. The paradox is...

  22. September 15, 2014

    Lessons in failure from the error management gurus

    How do, and how should, businesses handle failure? Employers often talk about empowering people to take risks and learn...

  23. August 25, 2014

    Chi-Med draws on the past for the future

    Hutchison China MediTech represents the past and the future of China’s pharmaceuticals industry. Much of its revenues...

  24. July 16, 2014

    Eli Lilly joins forces with UK biotech to develop cancer drugs

    Eli Lilly has entered the race to develop a new generation of oncology drugs, which harness the immune system to kill...

  25. June 12, 2014

    Taxing time ahead as offshore rules come under more scrutiny

    ‘Golden age’ for offshore cash The OECD called it “the golden age” of tax planning: a period in which multinational...

  26. June 8, 2014

    Japanese drugmakers sit out global M&A party

    Japanese drugmakers have been conspicuous by their absence from the dealmaking bonanza sweeping the sector across...

  27. May 7, 2014

    Pharma and Pfizer’s reputations on the line

    The proportion of UK cancer patients who survive 10 years after diagnosis rose from 25 per cent in the 1970s to 50 per...

  28. April 22, 2014

    Eli Lilly: animal spirits

    Eli Lilly has nothing if not momentum. Over six months, the drugmaker’s shares have returned 23 per cent, among the...

  29. April 22, 2014

    Eli Lilly: momentum and mean reversion

    Eli Lilly The investment universe has a Zoroastrian structure. The battle is between momentum and mean reversion....

  30. April 22, 2014

    Novartis buys GSK business for up to $16bn in restructuring

    Novartis and GlaxoSmithKline have agreed to swap a series of assets in a multibillion-dollar deal that will reshape two...

  31. April 11, 2014

    Big pharma: Storehouse of trouble

    Mark Lanier is no ordinary trial lawyer. His success has been such that he lives on a 25-acre estate near Houston and...

  32. April 8, 2014

    Takeda and Eli Lilly fall foul of  jury in Actos trial

    For Mark Lanier, it was the biggest victory of his career as a plaintiff’s lawyer: a $9bn award for punitive damages...

  33. April 8, 2014

    Takeda: a fine mess

    It’s a big, scary number. A US court has hit the Japanese drug company Takeda with a $6bn penalty after finding that it...

  34. FT Alphaville

    April 8, 2014

    The (early) Lunch Wrap

    Good morning New York, FT ALPHAVILLE David revisits the €1,000,000,000,000 question, what will the ECB do? Dan notes...

  35. April 8, 2014

    Takeda ordered to pay record $6bn over diabetes drug claim

    A US jury has hit two drug companies with a record $9bn fine for hiding an alleged link between a best-selling diabetes...

  36. February 19, 2014

    Eli Lilly jumps after cancer drug trial

    Shares in Eli Lilly climbed after the US pharmaceuticals group said a study of a lung cancer treatment increased...

  37. December 26, 2013

    Ethics: End of the hard sell?

    When Johnson & Johnson wanted to boost prescriptions of Natrecor, a heart medicine, it channelled more than $100,000...

  38. November 14, 2013

    Drug manufacturers seek to expand the range of treatments

    Three companies have long dominated the commercial battle over insulin. For nearly a century since it was first...

Search for Eli Lilly & Co and

RELATED VIDEOS

Videos from FT.com that closely match this topic

  1. Lex on whether 26% share climb is overly optimistic...
    July 22, 2015

    Lex on whether 26% share climb is overly optimistic

  2. Eli Lilly's John Lechleiter says pharma must reach out to inn...
    June 15, 2012

    Eli Lilly's John Lechleiter says pharma must reach out ...